This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rikako Hayashi: Pharmaceutical Innovation for ME/CFS and Fibromyalgia.
Introduction
Rikako Hayashi is an inventor associated with Osaka, Japan, and Mitsubishi Tanabe Pharma Corporation. Her patent work addresses potential treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia.
Latest Patents
Hayashi is associated with 1 patent, titled “Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome.” The invention describes a therapeutic agent for ME/CFS or fibromyalgia containing 2-amino-2-[2-(4-heptyloxy-3-trifluoromethylphenyl)ethyl]propane-1,3-diol, or a pharmaceutically acceptable salt of that compound. The patent presents a proposed therapeutic approach for these conditions.
Career Highlights
Hayashi’s listed work connects her to pharmaceutical research at Mitsubishi Tanabe Pharma Corporation. Her patent focuses on a compound identified for potential use in treating ME/CFS and fibromyalgia.
Collaborations
Hitoshi Izaki and Yoshiari Yanai are identified as Hayashi’s coworkers. Their names provide context for her professional connections, though the supplied information does not specify their roles in the patent.
Conclusion
Rikako Hayashi’s patent work reflects a pharmaceutical research focus on potential treatments for ME/CFS and fibromyalgia, developed in connection with Mitsubishi Tanabe Pharma Corporation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile